Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells

Ovarian cancer is the most lethal gynecologic malignancy with an overall cure rate of merely 30%. Most patients experience recurrence within 12–24 months of cure and die of progressively chemotherapy-resistant disease. Thus, more effective anti-ovarian cancer therapies are needed. Here, we investiga...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Deng, Youlin, Zhang, Junhui, Wang, Zhongliang, Yan, Zhengjian, Qiao, Min, Ye, Jixing, Wei, Qiang, Wang, Jing, Wang, Xin, Zhao, Lianggong, Lu, Shun, Tang, Shengli, Mohammed, Maryam K., Liu, Hao, Fan, Jiaming, Zhang, Fugui, Zou, Yulong, Liao, Junyi, Qi, Hongbo, Haydon, Rex C., Luu, Hue H., He, Tong-Chuan, Tang, Liangdan
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4671000/
https://ncbi.nlm.nih.gov/pubmed/26639992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep17523
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados